DaVita Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
2025.11.25 22:20
portai
I'm PortAI, I can summarize articles.

DaVita Inc. shares rose 1.57% to $121.37 on Tuesday, underperforming compared to competitors like UnitedHealth Group, Icon PLC, and Quest Diagnostics, despite a positive market session. The stock remains 32.42% below its 52-week high of $179.60. The S&P 500 and Dow Jones also saw gains.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of DaVita Inc. (DVA) rallied 1.57% to $121.37 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.91% to 6,765.88 and the Dow Jones Industrial Average rising 1.43% to 47,112.45. DaVita Inc. closed 32.42% short of its 52-week high of $179.60, which the company reached on January 31st. The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as UnitedHealth Group Inc. (UNH) rose 2.27% to $326.28, Icon PLC (ICLR) rose 6.07% to $174.53, and Quest Diagnostics Inc. (DGX) rose 0.93% to $192.35. Data source: Dow Jones Market Data, FactSet. Data compiled November 25, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 11-25-25 1720ET
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer